BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 16, 2004
View Archived Issues
Biliverdin protective against endotoxin-induced acute lung injury
Read More
Human serpin with potential to heal diabetic ulcers
Read More
Increased survival achieved with efaproxiral in patients with brain metastases
Read More
Preliminary data suggest epratuzumab plus rituximab is safe and effective in NHL
Read More
Phase I data on XR-5944 in patients with refractory advanced cancer
Read More
Peripheral efficacious kappa opioid agonist with unprecedented selectivity
Read More
Aptosyn phase III study in NSCLC fails to meet endpoints
Read More
Teva and Active Biotech sign laquinimod licensing deal
Read More
FDA agrees to two pivotal protocols for pexelizumab
Read More
EDEMA1 study of DX-88 meets primary endpoint
Read More
ARRY-142886 enters phase I trial for advanced cancer
Read More
A6 enters phase II trial to prevent clinical relapse in ovarian cancer patients
Read More
Second of two phase III trials for Viramidine under way
Read More
Vertex and Mitsubishi sign agreement for VX-950 in Japan and Far East
Read More
Evotec and Neuronova enter drug discovery agreement in depression, anxiety
Read More
Hemispherx submits clinical trial protocol to FDA for Alferon N
Read More
Biovail's NDA for novel dosage form of citalopram accepted for review
Read More
First quarter 2004 clinical development highlights announced by PDL
Read More
Delayed tumor progression found with atrasentan in prostate cancer
Read More
Therapeutic benefits of PT-141 plus Viagra in erectile dysfunction
Read More
Promising effects of the protease inhibitor PL-100 against resistant HIV strains
Read More
Autologous Xcellerated T-cells show antitumor efficacy in phase I/II clinical trials
Read More
Two series of mitotic kinesin KSP inhibitors claimed by Merck
Read More
Novel prostaglandin D2 antagonists under study at Merck Frosst
Read More
New HIV integrase inhibitors discovered by Pfizer researchers
Read More
Cyclodextrin complexes of opioid peptide and their use in pain and inflammation
Read More
Novel GABA-A ligands and their use covered by Merck patent
Read More
Nordic Bioscience researchers claim new GADPH and/or IAMP inhibitors
Read More
Novogen patent discloses isoflavonoid-based antiproliferative agents
Read More
New antitumor agents developed by Sanofi-Synthelabo scientists
Read More
